CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

FDA Expedited Investigational New Drug (IND) Pilot Program

RegulatoryPositive
AI Analysis

Summary

The FDA announced the Expedited IND Pilot Program under HHS Operation TrialBlazer to accelerate first-in-human clinical trials while maintaining safety and scientific standards.

Importance:2/10
Sentiment:
0.30
FDAINDClinical TrialsRegulatory InitiativeFirst-in-HumanTrialBlazer

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 18, 2026 7:55 PM

Read Original